Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 13/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 13/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | F2R | P25116 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7448545 | 0.80 | SMN1; SMN2 (0.53) | ALDH1A1SMN1; SMN2NPC1CYP2C19POLB | |
| SCHEMBL6539363 | 0.78 | SMN1; SMN2 (0.62) | ITGB3ITGA2BALDH1A1F2RSMN1; SMN2 | |
| SCHEMBL6539357 | 0.78 | SMN1; SMN2 (0.62) | ITGB3ITGA2BALDH1A1F2RSMN1; SMN2 | |
| SCHEMBL8549480 | 0.78 | BCHE (0.35) | SMN1; SMN2MAPK1NPC1CYP2D6CYP2C9 | |
| SCHEMBL27339333 | 0.76 | ITGB3 (0.52) | ITGB3ITGA2BALDH1A1F2RHPGD | |
| SCHEMBL17646360 | 0.72 | ALDH1A1 (0.72) | ALDH1A1HPGDSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL7311015 | 0.72 | ALDH1A1 (0.72) | ALDH1A1HPGDSMN1; SMN2KDM4ENPC1 | |
| SCHEMBL7398369 | 0.70 | GRIN2B (0.35) | ALDH1A1CYP2D6CYP2C9 | |
| SCHEMBL25453024 | 0.69 | MEN1 (0.57) | ITGB3ITGA2BALDH1A1F2R | |
| SCHEMBL3277860 | 0.69 | SMN1; SMN2 (0.71) | ALDH1A1HPGDSMN1; SMN2KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010051730-A1 | Beta-alanine derivative and a process for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051730-A1 | Beta-alanine derivative and a process for the preparation thereof | F13B, FGB, TGFB1 | ITGB3 52/4885ITGA2B 14/4885ALDH1A1 416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.